Showing results (211-220 of 2,397) with videos related to

Sort By:
Pageof 240
Translational Lung Cancer Research|September 21, 2020
Rates of positive lung cancer screening examinations in academic versus community practiceLouise M Henderson, Leon Bacchus, Thad Benefield, et al.
Translational Lung Cancer Research|September 21, 2020
Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumabGiuseppe Luigi Banna, Diego Signorelli, Giulio Metro, et al.
Translational Lung Cancer Research|September 21, 2020
Microbiota dysbiosis in lung cancer: evidence of association and potential mechanismsNana Xu, Lei Wang, Chenxi Li, et al.
Translational Lung Cancer Research|March 15, 2021
Comprehensive genomic profiling of combined small cell lung cancerJing Zhang, Liping Zhang, Jie Luo, et al.
Translational Lung Cancer Research|March 15, 2021
PD-1 restrains IL-17A production from γδ T cells to modulate acute radiation-induced lung injuryYuling Sheng, Kun Chen, Wei Jiang, et al.
Translational Lung Cancer Research|March 15, 2021
KRASG12C/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinomaNikolaj Frost, Jens Kollmeier, Claudia Vollbrecht, et al.
Translational Lung Cancer Research|March 15, 2021
Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lungYuichiro Kai, Vishwa Jeet Amatya, Kei Kushitani, et al.
Translational Lung Cancer Research|March 15, 2021
Prognostic and predictive effect of KRAS gene copy number and mutation status in early stage non-small cell lung cancer patientsAndrea S Fung, Maryam Karimi, Stefan Michiels, et al.
Translational Lung Cancer Research|March 15, 2021
The prognostic impact of circulating homeobox A9 methylated DNA in advanced non-small cell lung cancerSara Witting Christensen Wen, Rikke Fredslund Andersen, Torben Frøstrup Hansen, et al.
Translational Lung Cancer Research|March 15, 2021
Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitorsHongsik Kim, Hyun Ae Jung, Se-Hoon Lee, et al.
Pageof 240